Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
Background Considering the widespread risk of collider bias and confounding by indication in previous research, the associations between renin‐angiotensin aldosterone system (RAAS) inhibitor use and COVID‐19 remain unknown. Accordingly, this study tested the hypothesis that RAAS inhibitors influence...
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
Wiley
2021-08-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Acceso en liña: | https://www.ahajournals.org/doi/10.1161/JAHA.120.021154 |